Overview:

This program will be delivered as a series of 8 live, CME-certified virtual meetings in collaboration with ACCC-affiliated Oncology State Societies, supported by an enduring online activity. Using an interactive, case-based format tailored to community oncology practice, these virtual meetings include expert presentations on recent data from clinical trials of follicular lymphoma, followed by case presentations, discussions and learner question and answers. The initiative is designed to translate evolving clinical evidence into practical, real-world decision-making and support personalized care for patients with follicular lymphoma.

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Apply guideline recommendations and practice-changing advances to treatment selection in relapsed/refractory FL
• Analyze evidence for current and emerging therapeutics in the context of sequencing in FL
• Assess data from ongoing studies that impact the evolving treatment paradigms in FL

Target Audience:

This educational program is directed toward community-based medical oncologists, hematologic oncologists, hematologists, hematopathologists, NP/PAs, nurses, pharmacists and other healthcare professionals involved in the treatment of FL.

Accreditation/Credit Designation:

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour. 

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Acknowledgment of Educational Support

This activity is supported by an educational grant from Incyte Corporation, Inc.

Have a question for the PER® team?

Oncology Inquiries: onc-info@gotoper.com

Eye Care Inquiries: eye-info@gotoper.com

Multispecialty Inquiries: multi-info@gotoper.com